Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 41, Issue 7, 2003, Pages 316-322

  Georgarakis, M ^a   Zougrou, F ^a   Tzavara, S ^b   Kontopoulos, G ^c   Tsiptsios, I ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Integrated Laboratory Services   (Greece)

^c Hospital St Paulus   (Greece)

Author keywords

Bioequivalence; Clinical pharmacokinetics; Isotretinoin

Indexed keywords

A CNOTREN; ISOTRETINOIN;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIGHT; MALE; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; THERMOSTABILITY;

EID: 0038606526     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41316     Document Type: Article

References (15)

1. Allen JB, Bloxhem DP 1989 The pharmacology and pharmacokinetics of the retinoids. Pharmacol Ther 40: 1-27
2. Bollag W, Geiger LM 1984 The development of retinoids in dermatology. In: Cunliffe, Miller (eds) Retinoid Therapy: A Review of Clinical and Laboratory Research. Proceedings of an International Conference. MTP Press Limited, London, pp 1-7
3. Brazell RK, Colburn WA 1982 Pharmacokinetics of the retinoids isotretinoine and etratinate. J Am Acad Dermatol 6: 643-651
4. Brazell RK, Vane FM, Ehmann CW, Colburn WA 1983 Pharmacokinetics of isotretinoin during repetitive dosing in patients. Eur J Clin Pharmacol 24: 695-702
5. Chow S, Liu P 1992 Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker, New York
6. Committee for Proprietary Medicinal Products (CPMP) 1998 Note for guidance on the investigation of bioavailability and bioequivalence. London
7. Gadde RR, Burton FW 1992 Simple reversed-phase high-performance liquid chromatographic method for 13-cis-retinoic acid in serum. J Chromatogr 593: 41-46
8. Goodman DS 1984 Vitamin A and retinoids in health and disease. N Engl J Med 310: 1023-1031
9. Layton AM, Cunliffe WJ 1992 Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 27: S2-S7
10. Lunek RW, Colburn WA 1985 Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 10: 38-62
11. Orfanos CE, Ehlert R, Gollnick H 1987 The retinoids: a review of their clinical pharmacology and therapeutic use. Drug 34: 459-503
12. Orfanos CE, Zouboulis CC, Almond-Rooster B, Geilen GC 1997 Current use and future potential role of retinoids in dermatology. Drugs 53: 358-388
13. Teerling T, Copper MP, Klaassen I, Mbraakhuis BJ 1997 Simultaneous analysis of retinal, all-trans and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction. J Chromatogr B 694: 83-92
14. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS 1984 Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other disorders. Drugs 28: 6-37
15. Wiegand UW, Chou RC 1998 Pharmacokinetics of oral isotretinoine. J Am Acad Dermatol 39 (Suppl): 8-12